top of page
Search


TBnet News June 2026
Today: TBnet/ptbnet Webinar – “MSF TACTiC project to improve the management of childhood tuberculosis: experiences from Pakistan” Join us today - Thursday, July 2 at 5:00 pm CEST - for the joint TBnet/ptbnet webinar titled “MSF TACTiC project to improve the management of childhood tuberculosis: experiences from Pakistan”. The webinar will also begin with the world-premiere of a short video to commemorate the 20th Anniversary of TBnet! We look forward to seeing many of you t
anneoleischeck
Jul 24 min read


Together against antibiotic-resistant tuberculosis in Europe
On 8–9 June 2026, more than 50 leading specialists in the field gathered in Chisinau, Republic of Moldova, for the 1st Antimicrobial Stewardship in Tuberculosis Conference. A further 50 experts joined online, with participants representing more than 40 countries across the World Health Organization (WHO) European Region. The conference was organized by the Tuberculosis Network European Trials Group (TBnet), a non-governmental organization in the field of tuberculosis dedicate
anneoleischeck
Jun 122 min read


2025: A Year in Review
The year 2025 marked another milestone year in TB and NTM-focused research, including diagnostics, epidemiology and treatment. In light of the rapid expansion of evidence each year, TBnet is committed to support TB clinicians and researchers in remaining up-to-date with the significant findings in mycobacterial infection and disease. Following on from last year’s edition, the Year in Review for 2025 has been published in Pathogens and Immunity as TBnet’s partner journal. The
anneoleischeck
Jun 121 min read


TBnet News May 2026
The First TBnet/WHO Europe Conference on Antimicrobial Stewardship in TB Antimicrobial resistance (AMR) remains one of the leading global health threats, with tuberculosis (TB) playing a major role in this challenge. In 2024, an estimated 390,000 people developed multidrug- or rifampicin-resistant TB (MDR/RR-TB). In response, the World Health Organization has identified rifampicin-resistant Mycobacterium tuberculosis as a priority pathogen requiring urgent action. Althoug
anneoleischeck
May 283 min read
bottom of page